Below is a concise month-by-month overview of expected results from daily use of one Prime Biome gummy, based on its claims, ...

The formula is designed to work for people of all ages and body conditions. Relevant clinical studies and research-based ...

ProDentim is a teeth health supplement made using natural probiotics and teeth-essential nutrients that can tackle the ...

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

PHOENIX, April 23, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (“AMPS”), a diversified healthcare technology company supporting transparent, affordable medical and prescription ...

Paris, France (April 23, 2025 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the first quarter of 2025 reached Euro 6,848 million, representing a year-on-year increase of ...

Partnered Assets: SIRPα antagonists BI 765063 and BI 770371, an improved next generation SIRPα inhibitor, developed in partnership with Boehringer Ingelheim: Rapid Oral Abstracts of the Phase 1 ...

All shares of common stock and pre-funded warrants to be sold in the offering will be offered by Rezolute. The closing of the offering is expected to occur on or about April 24, 2025, subject to the ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the ...

By delivering up-to-date, multimodal data, OneMedNet expands its reach into the domain of AI-ready data for healthcare intelligence. Partnering with Protege is strategically significant because the AI ...

The Fortel ® Ulcer Test is a simple, quick and user-friendly diagnostic tool that detects antibodies to H. pylori, a bacterium known to cause peptic ulcer disease, dyspepsia, and gastric cancer. The ...

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.